CN106177415A - 一种治疗失眠症的中西药组合物及制备方法 - Google Patents
一种治疗失眠症的中西药组合物及制备方法 Download PDFInfo
- Publication number
- CN106177415A CN106177415A CN201610702975.8A CN201610702975A CN106177415A CN 106177415 A CN106177415 A CN 106177415A CN 201610702975 A CN201610702975 A CN 201610702975A CN 106177415 A CN106177415 A CN 106177415A
- Authority
- CN
- China
- Prior art keywords
- chinese
- herba
- western
- treatment
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 47
- 206010022437 insomnia Diseases 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000003814 drug Substances 0.000 claims abstract description 47
- 210000000582 semen Anatomy 0.000 claims abstract description 33
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 241001062995 Ziziphora Species 0.000 claims abstract description 17
- 244000123550 Adenia heterophylla Species 0.000 claims abstract description 16
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960003529 diazepam Drugs 0.000 claims abstract description 16
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 16
- 229960003019 loprazolam Drugs 0.000 claims abstract description 15
- UTEFBSAVJNEPTR-RGEXLXHISA-N loprazolam Chemical compound C1CN(C)CCN1\C=C/1C(=O)N2C3=CC=C([N+]([O-])=O)C=C3C(C=3C(=CC=CC=3)Cl)=NCC2=N\1 UTEFBSAVJNEPTR-RGEXLXHISA-N 0.000 claims abstract description 15
- 239000004615 ingredient Substances 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract description 9
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 240000002853 Nelumbo nucifera Species 0.000 claims 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims 1
- 150000003851 azoles Chemical class 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 230000003760 hair shine Effects 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 19
- 210000003734 kidney Anatomy 0.000 abstract description 15
- 210000004185 liver Anatomy 0.000 abstract description 13
- 210000002216 heart Anatomy 0.000 abstract description 12
- 230000003860 sleep quality Effects 0.000 abstract description 9
- 210000002784 stomach Anatomy 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 238000005728 strengthening Methods 0.000 abstract description 7
- 230000001717 pathogenic effect Effects 0.000 abstract description 6
- 230000002936 tranquilizing effect Effects 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000001914 calming effect Effects 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 3
- 238000012423 maintenance Methods 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 210000001835 viscera Anatomy 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 description 20
- 230000007958 sleep Effects 0.000 description 19
- 235000009508 confectionery Nutrition 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 230000008901 benefit Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 229960002336 estazolam Drugs 0.000 description 6
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010029216 Nervousness Diseases 0.000 description 2
- 206010029412 Nightmare Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010061481 Renal injury Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 208000005368 osteomalacia Diseases 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010058117 Ocular icterus Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000037114 Symptom Flare Up Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001062 anti-nausea Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000004926 tubular epithelial cell Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta (mosses)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗失眠症的中西药组合物及制备方法,制成所述中西药组合物有效成分的原料组成为:牛奶浆根、蒴莲、酸枣仁、响铃草、地梢瓜、榆叶、柏子仁、玄参、山毛藓、睡菜、南烛叶、新塔花、粟芽、麦冬、维生素B6、地西泮和氯普唑仑;本发明对中药材进行合理选择与配伍,具有益气健脾、活血通络、益气升提、宁心安神、滋肾养肝、清热降火、益脾胃等功效,能够在治疗失眠的同时起到养护失眠患者的心、肝、脾、肾等脏器的作用,兼具补益与治疗双重功效,并结合西药成分,进而达到协同增效的作用,提高睡眠质量,针对失眠症的治疗可达到速效治愈的目的。
Description
技术领域
本发明涉及医药技术领域,特别涉及一种治疗失眠症的中西药组合物及制备方法。
背景技术
失眠是指无法入睡或无法保持睡眠状态,导致睡眠不足。又称入睡和维持睡眠障碍,为各种原因引起入睡困难、睡眠深度或频度过短、早醒及睡眠时间不足或质量差等,是一种常见病。失眠往往会给患者带来极大的痛苦和心理负担,又会因为滥用失眠药物而损伤身体其他方方面面。但也有很多方法可以缓解和治疗失眠。
失眠的症状表现主要有:胡思乱想、睡眠质量不好、易被惊醒、入睡困难和恶梦不断。很多人在躺倒床上后会不由自主的胡思乱想,脑子里像放电影一样,怎么都停不下来,以致很难进入睡眠状态。有些人睡醒之后感觉和没睡一样,浑身酸痛,这就是睡眠质量不好导致的,出现这种情况应该认真找出原因并加以改善。睡眠较轻,难以进入深度睡眠,就会对周围的动静比较敏感,即使很小的声音也会被惊醒,也有的是对灯光比较敏感。入睡困难主要表现为不能熟睡,早醒、醒后无法再入睡。多梦也是失眠的症状之一,很多人会整晚噩梦,频频从恶梦中惊醒,严重影响睡眠质量。
许多研讨发现,许多疾病常常伴着失眠应运而生。睡觉质量欠佳常常会让人觉得心境烦躁、焦虑不安,而且失眠还会进一步致使人体的免疫力急剧下降,因而让许多疾病趁机找上了健康的人群。而且瑞典研讨人员研讨发现,如果没有正常的睡眠,那么人体血液中的胆固醇浓度就会变大,这样会很容易患上心脏病。失眠还会影响大脑的正常运作。正常的睡眠能够让人在工作中神清气爽、思维活络,但是如果长期没有正常的睡眠的话,大脑会一直处在一种工作的状态当中,这样会影响大脑的正常工作,直接影响工作中的办事效率,严重的还会有记忆力下降的情况发生。皮肤是许多女性都注重的一个问题,如果没有好的睡眠,那么人的皮肤就会变得单调、暗沉。欠佳的睡眠还会构成皮肤中毛细血管的阻塞,会让皮肤吸收不到满意的营养而失去光泽,加速皮肤老化。
现有治疗失眠的药物有中药,也有西药,西药见效快,但是副作用较大,中药虽然副作用小,但见效慢。为此,研究出一种疗效确切、无副作用、见效又快的治疗失眠症的药物是很有价值的。
发明内容
本发明提供了一种治疗失眠症的中西药组合物及制备方法;本发明对中药材进行合理选择与配伍,具有益气健脾、活血通络、益气升提、宁心安神、滋肾养肝、清热降火、益脾胃等功效,能够在治疗失眠的同时起到养护失眠患者的心、肝、脾、肾等脏器的作用,兼具补益与治疗双重功效,并结合西药成分,进而达到协同增效的作用,提高睡眠质量,针对失眠症的治疗可达到速效治愈的目的。
为实现上述目的,本发明的技术方案实施如下:
一种治疗失眠症的中西药组合物,制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:牛奶浆根56-76g、蒴莲51-71g、酸枣仁48-68g、响铃草48-68g、地梢瓜43-63g、榆叶36-56g、柏子仁36-56g、玄参31-51g、山毛藓31-51g、睡菜28-48g、南烛叶23-43g、新塔花18-38g、粟芽15-35g、麦冬15-35g;所述西药组分由以下重量数的原料配制而成:维生素B6 10-20mg、地西泮5-10mg、氯普唑仑0.5-1mg。
制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:牛奶浆根71g、蒴莲66g、酸枣仁63g、响铃草63g、地梢瓜58g、榆叶51g、柏子仁51g、玄参46g、山毛藓46g、睡菜43g、南烛叶38g、新塔花33g、粟芽30g、麦冬30g;所述西药组分由以下重量数的原料配制而成:维生素B6 17mg、地西泮8mg、氯普唑仑0.8mg。
制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:牛奶浆根66g、蒴莲61g、酸枣仁58g、响铃草58g、地梢瓜53g、榆叶46g、柏子仁46g、玄参41g、山毛藓41g、睡菜38g、南烛叶33g、新塔花28g、粟芽25g、麦冬25g;所述西药组分由以下重量数的原料配制而成:维生素B6 15mg、地西泮7mg、氯普唑仑0.7mg。
制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:牛奶浆根61g、蒴莲56g、酸枣仁53g、响铃草53g、地梢瓜48g、榆叶41g、柏子仁41g、玄参36g、山毛藓36g、睡菜33g、南烛叶28g、新塔花23g、粟芽20g、麦冬20g;所述西药组分由以下重量数的原料配制而成:维生素B6 13mg、地西泮6mg、氯普唑仑0.6mg。
一种治疗失眠症的中西药组合物的制备方法,包括以下工艺步骤:
(1)将牛奶浆根、蒴莲、响铃草、地梢瓜、榆叶、柏子仁、山毛藓、新塔花、粟芽和麦冬放入容器中,加入10倍量蒸馏水浸泡4小时后,加热煮沸4小时,提取;第二次加入8倍量蒸馏水加热煮沸3小时,提取;第三次加入6倍量蒸馏水加热煮沸2小时,提取;合并三次所得提取液,滤过,得滤液备用;
(2)将酸枣仁和玄参置于烤箱内200℃烘烤5-10分钟,取出,冷却至室温,粉碎成粗粉,水煎煮提取2-3次,每次1.5-2.5小时,合并滤液,浓缩成相对密度为1.15-1.32的浸膏,备用;
(3)将睡菜和南烛叶入榨机榨出汁液,过滤,留汁液备用;
(4)将维生素B6、地西泮和氯普唑仑分别粉碎,得到过160目的细粉,合并,备用;
(5)将上述所得的滤液、浸膏、汁液和细粉混合,加入药用辅料糊精搅拌均匀,γ射线照射灭菌,按常规方法制成0.5g/粒的胶囊,密封包装,即为所述的治疗失眠症的中西药组合物。
本发明所用中药的药性如下:
牛奶浆根:味甘、辛,性温;归肺、脾、肾经。益气健脾,活血通络,祛风除湿。主劳倦乏力,食少,乳汁不下,脾虚白带,脱肛,月经不调,头风疼痛,跌打损伤,风湿性关节痛。《闽东本草》载:“补中益气,健脾化湿,强筋壮骨,消肿,活血解毒。治中气虚弱,气血衰微,四肢酸软,筋骨不利,经闭,乳汁不通。”
蒴莲:味甘、微苦,性凉。祛风通络,益气升提。主胃脘痛,风湿痹痛,子宫脱垂。
酸枣仁:味甘,性平;归心、脾、肝、胆经。宁心安神,养肝,敛汗。主虚烦不眠,惊悸怔忡,体虚自汗、盗汗。《本草再新》载:“平肝理气,润肺养阴,温中利湿,敛气止汗,益志,聪耳明目。”
响铃草:味苦、微酸,性寒;归肺经。滋肾养肝,止咳平喘,利湿解毒。主耳鸣,耳聋,头目眩晕,遗精,月经过多,白带,久咳痰血,哮喘,肾炎,小便不利,扁桃体炎,腮腺炎,疔疮肿毒。《四川中药志》载:“补中益气,治耳鸣耳聋,头目眩晕,肾亏遗精,及妇女干血劳。”
地梢瓜:味甘,性凉;归肺经。补肺气,清热降火,生津止渴,消炎止痛。主虚火上炎,咽喉疼痛,气阴不足,神疲健忘,虚烦口渴,头昏失眠,产后体虚,乳汁不足。
榆叶:味甘,性平。清热利尿,安神,祛痰止咳。主水肿,小便不利,石淋,尿浊,失眠,暑热困闷,痰多咳嗽,酒(查皮)鼻。《纲目》载:“同酸枣仁等分蜜丸,日服,治胆热虚劳不眠。”
柏子仁:味甘,性平;归心、肾、大肠经。养心安神,敛汗,润肠通便。主惊悸怔忡,失眠健忘,盗汗,肠燥便秘。《纲目》载:“柏子仁,性平而不寒不燥,味甘而补,辛而能润,其气清香,能透心肾,益脾胃,盖上品药也,宜乎滋养之剂用之。”
玄参:味甘、苦、咸,性微寒;归肺、胃、肾经。清热凉血,滋阴降火,解毒散结。主温热病热和营血,身热,烦渴,舌绛,发斑,骨蒸劳嗽,虚烦不寤,津伤便秘,目涩昏花,咽喉肿痛,瘰疬痰核,痈疽疮毒。《日华子本草》载:“治头风热毒游风,补虚劳损,心惊烦躁,劣乏骨蒸,传尸邪气,止健忘,消肿毒。”
山毛藓:味甘、淡,性平。养阴清热,养血安神。用于阴虚潮热,神经衰弱,癫狂,筋骨疼痛。
睡菜:味甘、微苦,性寒;归心、脾经。健脾消食,养心安神,清热利尿。主胃炎,消化不良,心悸失眠,湿热黄疸,胆囊炎,水肿,小便不利或赤热涩痛。《北方常用中草药手册》载:“健脾消食,养心安神。治胃炎,胃痛,消化不良、心悸失眠、心神不安。”
南烛叶:味酸、涩,性平;归心、脾、肾经。益肠胃,养肝肾。主脾胃气虚,久泻,少食,肝肾不足,腰膝乏力,须发早白。《本草拾遗》载:“止泄除睡,强筋益气力。”
新塔花:味辛,性凉;归心、肾经。疏散风热,清抻头目,安神强壮。主风热感冒,头痛,咽痛,失眠,多梦,软骨病,阳痿。《新疆中草药手册》载:“治失眠,心慌,软骨病,阳萎。”
粟芽:味苦,性微温;归脾、胃经。健脾,消食。主食积胀满,不思饮食。《山西中药志》载:“健脾,消食。治食滞胀满,食欲不佳。”
麦冬:味甘、微苦,性寒;归肺、胃、心经。滋阴润肺,益胃生津,清心除烦。主肺燥干咳,肺痈,阴虚劳嗽,津伤口渴,消渴,心烦失眠,咽喉疼痛,肠燥便秘,血热吐衄。《名医别录》载:“疗身重目黄,心下支满,虚劳客热,口干烦渴,止呕吐,愈痿蹶,强阴益精,消谷调中,保神,定肺气,安五脏,令人肥健。”
本发明与现有技术相比,具有以下有益效果:
本发明对中药材进行合理选择与配伍,具有益气健脾、活血通络、益气升提、宁心安神、滋肾养肝、清热降火、益脾胃等功效,能够在治疗失眠的同时起到养护失眠患者的心、肝、脾、肾等脏器的作用,兼具补益与治疗双重功效,并结合西药成分,进而达到协同增效的作用,提高睡眠质量,针对失眠症的治疗可达到速效治愈的目的。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明中西药组合物有效成分的原料组成及重量为:牛奶浆根74g、蒴莲69g、酸枣仁66g、响铃草66g、地梢瓜60g、榆叶54g、柏子仁54g、玄参48g、山毛藓48g、睡菜46g、南烛叶41g、新塔花36g、粟芽19g、麦冬19g、维生素B6 19mg、地西泮9mg、氯普唑仑0.9mg。
本发明中西药组合物的制备方法,包括以下工艺步骤:
(1)将牛奶浆根、蒴莲、响铃草、地梢瓜、榆叶、柏子仁、山毛藓、新塔花、粟芽和麦冬放入容器中,加入10倍量蒸馏水浸泡4小时后,加热煮沸4小时,提取;第二次加入8倍量蒸馏水加热煮沸3小时,提取;第三次加入6倍量蒸馏水加热煮沸2小时,提取;合并三次所得提取液,滤过,得滤液备用;
(2)将酸枣仁和玄参置于烤箱内200℃烘烤5-10分钟,取出,冷却至室温,粉碎成粗粉,水煎煮提取2-3次,每次1.5-2.5小时,合并滤液,浓缩成相对密度为1.15-1.32的浸膏,备用;
(3)将睡菜和南烛叶入榨机榨出汁液,过滤,留汁液备用;
(4)将维生素B6、地西泮和氯普唑仑分别粉碎,得到过160目的细粉,合并,备用;
(5)将上述所得的滤液、浸膏、汁液和细粉混合,加入药用辅料糊精搅拌均匀,γ射线照射灭菌,按常规方法制成0.5g/粒的胶囊,密封包装,即为所述的治疗失眠症的中西药组合物。
用法用量:口服,每日1次,每次1粒(每片0.5g),5天为一疗程,2到4个疗程即可痊愈,病情严重者遵医嘱酌增用量。
实施例2
本发明中西药组合物有效成分的原料组成及重量为:牛奶浆根71g、蒴莲66g、酸枣仁63g、响铃草63g、地梢瓜58g、榆叶51g、柏子仁51g、玄参46g、山毛藓46g、睡菜43g、南烛叶38g、新塔花33g、粟芽30g、麦冬30g、维生素B6 17mg、地西泮8mg、氯普唑仑0.8mg。
本实施例中西药组合物制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明中西药组合物有效成分的原料组成及重量为:牛奶浆根66g、蒴莲61g、酸枣仁58g、响铃草58g、地梢瓜53g、榆叶46g、柏子仁46g、玄参41g、山毛藓41g、睡菜38g、南烛叶33g、新塔花28g、粟芽25g、麦冬25g、维生素B6 15mg、地西泮7mg、氯普唑仑0.7mg。
本实施例中西药组合物制备方法工艺步骤及用法用量与实施例1相同。
实施例4
本发明中西药组合物有效成分的原料组成及重量为:牛奶浆根61g、蒴莲56g、酸枣仁53g、响铃草53g、地梢瓜48g、榆叶41g、柏子仁41g、玄参36g、山毛藓36g、睡菜33g、南烛叶28g、新塔花23g、粟芽20g、麦冬20g、维生素B6 13mg、地西泮6mg、氯普唑仑0.6mg。
本实施例中西药组合物制备方法工艺步骤及用法用量与实施例1相同。
实验部分(动物急性毒性试验):
1、实验材料:实验动物为健康小鼠,雌雄各半,体重25±1g,每组44只小鼠。实验药物选用本发明中西药组合物、艾司唑仑片。实验材料选用ALT测定试剂盒。
2、方法:
实验组:取本发明中西药组合物1粒溶解在10ml水中,对小鼠进行灌胃,灌胃容积为10ml/kg,每晚各一次,共20天。
对照组:取艾司唑仑片1片溶解在10ml水中,对小鼠进行灌胃,灌胃容积为10ml/kg,每晚各一次,共20天。
空白组:服用相同量的生理盐水,每晚各一次,共20天。
3、检测及检测结果:
(1)、肝脏损伤检测:20天后,小鼠眼眶取血,分离血清。测定血清ALT活性。
结果:艾司唑仑片对照组小鼠血清ALT活性明显高于试验组。
讨论:根据以上实验结果可知,与常规药物艾司唑仑片相比,本申请中的中西药组合物可极大降低对肝脏损伤程度。
(2)、肾脏损伤检测:光镜检查。
结果:对照组肾组织光镜检查可见肾小球明显增大,系膜细胞轻度增生,肾小球毛细血管基底膜弥漫性增厚,基质增多,近端肾小管上皮细胞呈现大量空泡变性。实验组和空白组小鼠肾小球及小管间质未见明显的病理改变。
讨论:根据以上实验结果可知,与常规药物艾司唑仑片相比,本申请中的中西药组合物可以极大降低对肾脏的损伤程度。
临床资料:
1、病例选择:
选择我院或外院确诊的失眠症患者390例临床观察,病人随机分成治疗组、对照组A、对照组B三组,治疗组130例,其中男性65例,女性65例,年龄28-65岁,平均年龄42.1岁,病程1个月-1年;对照组A130例,其中男性66例,女性64例,年龄28-64岁,平均年龄41.9岁,病程1个月-1年;对照组B130例,其中男性64例,女性66例,年龄27-65岁,平均年龄41.8岁,病程1个月-1年;三组病例的病程、症状轻重程度基本一致,无显著差异,具有可比性。
2、药物选择:
治疗组患者服用本发明中西药组合物,每日1次,每次1粒(每片0.5g),晚饭后临睡前服用,5天为一疗程,连续服用2到4个疗程即可痊愈,病情严重者遵医嘱酌增用量。
对照组A服用艾司唑仑片,按说明书用,病情严重者遵医嘱酌增用量。
对照组B服用舒眠胶囊,按说明书用,病情严重者遵医嘱酌增用量。
3、疗效判定:
(1)治愈:胡思乱想、睡眠质量不好、易被惊醒、入睡困难、恶梦不断等症状消失,身体恢复正常。
(2)有效:上述症状有所缓解。
(3)无效:病症无变化。
4、结果:
以上结果显示,治疗组治愈率和总有效率明显高于对照组。
典型病例举例:
1、谢某,女,60岁,务农。患者2年前和儿媳吵架后出现入睡困难、烦躁、心慌、食欲下降等症状,并日渐加重,在当地诊所给予药物治疗后未有明显好转。为求进一步诊治,来我院就诊,诊断为失眠症。给予服用本发明中西药组合物3个疗程,上述症状全部消失,痊愈,随访,未复发。
2、郭某,男,54岁,教师。患者平素睡眠质量较差,稍有声响就很容易醒,偶尔入睡困难,后上述症状加重,入睡困难次数增加,夜里睡眠不足4小时。来我院就诊,经检查确诊为失眠症。给予服用本发明中西药组合物1个疗程,上述症状明显好转;继续服用本发明中西药组合物3个疗程,上述症状消失,痊愈,随访,未复发。
3、辛某,女,43岁,销售员。患者因长时间在超声环境下工作出现胸闷、恶心、食欲不振等症状,并逐渐加重。服用本发明中西药组合物2个疗程后,上述症状明显好转;继续服用本发明中西药组合物2个疗程后,上述症状消失,痊愈,随访,未复发。
4、习某,男,38岁,律师。患者经常为准备资料彻夜不眠,2年前出现失眠多梦、急躁、心烦、易惊醒等症状,服用维生素B1后效果理想,但易复发。后经医生推荐更换服用本发明中西药组合物,服用本发明中西药组合物1个疗程后,上述症状明显好转;继续服用本发明中西药组合物2个疗程后,上述症状消失,痊愈,随访,未复发。
5、翟某,男,29岁,银行职员。患者2年前出现入睡困难、恶心、食欲不振、头昏、头痛等症状,服用药物后无明显缓解。为求进一步诊治来我院,经检查确诊为失眠症。给予服用本发明中西药组合物1个疗程,上述症状明显好转;继续服用本发明中西药组合物2个疗程,上述症状消失,痊愈,随访,未复发。
6、宋某,女,23岁,学生。患者服用减肥药1个月后出现失眠、食欲不振、头晕等症状,在当地医院给予药物治疗后症状无明显改善。后更换服用本发明中西药组合物,服用1个疗程,上述症状明显好转;继续服用本发明中西药组合物2个疗程,上述症状消失,痊愈,随访,未复发。
Claims (5)
1.一种治疗失眠症的中西药组合物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:牛奶浆根56-76g、蒴莲51-71g、酸枣仁48-68g、响铃草48-68g、地梢瓜43-63g、榆叶36-56g、柏子仁36-56g、玄参31-51g、山毛藓31-51g、睡菜28-48g、南烛叶23-43g、新塔花18-38g、粟芽15-35g、麦冬15-35g;所述西药组分由以下重量数的原料配制而成:维生素B610-20mg、地西泮5-10mg、氯普唑仑0.5-1mg。
2.根据权利要求1所述的一种治疗失眠症的中西药组合物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:牛奶浆根71g、蒴莲66g、酸枣仁63g、响铃草63g、地梢瓜58g、榆叶51g、柏子仁51g、玄参46g、山毛藓46g、睡菜43g、南烛叶38g、新塔花33g、粟芽30g、麦冬30g;所述西药组分由以下重量数的原料配制而成:维生素B617mg、地西泮8mg、氯普唑仑0.8mg。
3.根据权利要求1所述的一种治疗失眠症的中西药组合物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:牛奶浆根66g、蒴莲61g、酸枣仁58g、响铃草58g、地梢瓜53g、榆叶46g、柏子仁46g、玄参41g、山毛藓41g、睡菜38g、南烛叶33g、新塔花28g、粟芽25g、麦冬25g;所述西药组分由以下重量数的原料配制而成:维生素B615mg、地西泮7mg、氯普唑仑0.7mg。
4.根据权利要求1所述的一种治疗失眠症的中西药组合物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:牛奶浆根61g、蒴莲56g、酸枣仁53g、响铃草53g、地梢瓜48g、榆叶41g、柏子仁41g、玄参36g、山毛藓36g、睡菜33g、南烛叶28g、新塔花23g、粟芽20g、麦冬20g;所述西药组分由以下重量数的原料配制而成:维生素B613mg、地西泮6mg、氯普唑仑0.6mg。
5.一种如权利要求1-4任一项所述的治疗失眠症的中西药组合物的制备方法,其特征在于:包括以下步骤:
(1)将牛奶浆根、蒴莲、响铃草、地梢瓜、榆叶、柏子仁、山毛藓、新塔花、粟芽和麦冬放入容器中,加入10倍量蒸馏水浸泡4小时后,加热煮沸4小时,提取;第二次加入8倍量蒸馏水加热煮沸3小时,提取;第三次加入6倍量蒸馏水加热煮沸2小时,提取;合并三次所得提取液,滤过,得滤液备用;
(2)将酸枣仁和玄参置于烤箱内200℃烘烤5-10分钟,取出,冷却至室温,粉碎成粗粉,水煎煮提取2-3次,每次1.5-2.5小时,合并滤液,浓缩成相对密度为1.15-1.32的浸膏,备用;
(3)将睡菜和南烛叶入榨机榨出汁液,过滤,留汁液备用;
(4)将维生素B6、地西泮和氯普唑仑分别粉碎,得到过160目的细粉,合并,备用;
(5)将上述所得的滤液、浸膏、汁液和细粉混合,加入药用辅料糊精搅拌均匀,γ射线照射灭菌,按常规方法制成0.5g/粒的胶囊,密封包装,即为所述的治疗失眠症的中西药组合物。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610702975.8A CN106177415A (zh) | 2016-08-22 | 2016-08-22 | 一种治疗失眠症的中西药组合物及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610702975.8A CN106177415A (zh) | 2016-08-22 | 2016-08-22 | 一种治疗失眠症的中西药组合物及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106177415A true CN106177415A (zh) | 2016-12-07 |
Family
ID=57524867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610702975.8A Pending CN106177415A (zh) | 2016-08-22 | 2016-08-22 | 一种治疗失眠症的中西药组合物及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106177415A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111420062A (zh) * | 2020-04-29 | 2020-07-17 | 漳州卫生职业学院 | 一种用于苯二氮卓类药物的协同增效剂 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1121811A (zh) * | 1994-05-12 | 1996-05-08 | 广东医学院医药科技开发中心 | 一组治疗神经症的药物配方及其制法 |
| CN101480481A (zh) * | 2008-01-07 | 2009-07-15 | 南京万舜源生物科技有限公司 | 一种用于改善睡眠的复方及制备方法和应用 |
| CN105267628A (zh) * | 2014-07-23 | 2016-01-27 | 熊爱华 | 一种治疗失眠的组合物中药 |
-
2016
- 2016-08-22 CN CN201610702975.8A patent/CN106177415A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1121811A (zh) * | 1994-05-12 | 1996-05-08 | 广东医学院医药科技开发中心 | 一组治疗神经症的药物配方及其制法 |
| CN101480481A (zh) * | 2008-01-07 | 2009-07-15 | 南京万舜源生物科技有限公司 | 一种用于改善睡眠的复方及制备方法和应用 |
| CN105267628A (zh) * | 2014-07-23 | 2016-01-27 | 熊爱华 | 一种治疗失眠的组合物中药 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111420062A (zh) * | 2020-04-29 | 2020-07-17 | 漳州卫生职业学院 | 一种用于苯二氮卓类药物的协同增效剂 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105194565A (zh) | 一种用于治疗心脏神经症的中药丸剂及制备方法 | |
| CN102727711B (zh) | 一种治疗慢性疲劳综合症的中药 | |
| CN103585449B (zh) | 用于治疗偏头痛的中药组合物 | |
| CN103920102B (zh) | 一种治疗原发性低血压的中药药物 | |
| CN104666475B (zh) | 一种治疗干燥综合症的黄连阿胶组合物及其应用 | |
| CN103405637B (zh) | 一种治疗神经官能症的药物及其制备方法 | |
| CN106177415A (zh) | 一种治疗失眠症的中西药组合物及制备方法 | |
| CN104127663A (zh) | 一种治疗阴虚火旺型经行失眠的中成药 | |
| CN107890521A (zh) | 一种护肝明目的中药组合物及其丸剂的制备方法 | |
| CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
| CN106110008A (zh) | 一种治疗产后抑郁症的中药制剂及制备方法 | |
| CN104547642A (zh) | 一种治疗女性纤维肌痛综合征的中药组合物 | |
| CN104688855B (zh) | 一种治疗慢性疲劳综合症的黄连阿胶组合物及其应用 | |
| CN103961578A (zh) | 一种治疗神经衰弱的中药药酒 | |
| CN104491364B (zh) | 一种治疗慢性淋巴细胞性甲状腺炎的药丸及制备方法 | |
| CN103341054B (zh) | 一种治疗心脑血管疾病的中药制剂及制备方法 | |
| CN103479868B (zh) | 一种治疗心虚胆怯型心律失常的中药及制备方法 | |
| CN102626503B (zh) | 一种舒心益智的中药口服液 | |
| CN107898990A (zh) | 一种治疗神经官能症的中药制剂及其制备方法 | |
| CN105998667A (zh) | 一种用于治疗低血压的药物及制备方法 | |
| CN105796962A (zh) | 一种安神的药物组合物及其制备方法 | |
| CN104707031A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
| CN105343794A (zh) | 一种治疗神经衰弱的药物及其制备方法 | |
| CN105233075A (zh) | 一种治疗冠心病的中药组合物 | |
| CN104173808B (zh) | 一种治疗肝火上炎型高血压的中药及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |